2018
DOI: 10.1159/000489640
|View full text |Cite
|
Sign up to set email alerts
|

The Dark Side of the Long-Term Use of Proton Pump Inhibitors in Chronic Liver Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…Gastric ulceration is a common cause of morbidity and mortality, with close to 53 million people developing gastric ulcers in the world each year (Global Burden of Disease Study 2013Collaborators, 2015. The conventional treatment of gastric ulcers involves use of proton pump inhibitors such as omeprazole and histamine-2 receptor antagonists like ranitidine, both of which act by reducing gastric acid secretion (Fernandes & Marinho, 2019). These drugs are often used in combination with antibiotics, particularly those that have activity against H. pylori (Gisbert et al, 2000).…”
Section: Introductionmentioning
confidence: 99%
“…Gastric ulceration is a common cause of morbidity and mortality, with close to 53 million people developing gastric ulcers in the world each year (Global Burden of Disease Study 2013Collaborators, 2015. The conventional treatment of gastric ulcers involves use of proton pump inhibitors such as omeprazole and histamine-2 receptor antagonists like ranitidine, both of which act by reducing gastric acid secretion (Fernandes & Marinho, 2019). These drugs are often used in combination with antibiotics, particularly those that have activity against H. pylori (Gisbert et al, 2000).…”
Section: Introductionmentioning
confidence: 99%